5.86 USD
▼-0.08-1.35%
盘后 5.81 -0.85%
2026-11-19
市值
$1.23B
市盈率
—
EPS
-1.46
股息率
—
52 周区间
5.77 – 16.44
成交量
3.09M
Beta
1.22
目标价
25.73
52W 低 5.7752W 高 16.44
价格走势
公司简介
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of ...